Cargando…
Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446262/ https://www.ncbi.nlm.nih.gov/pubmed/34253503 http://dx.doi.org/10.1016/j.htct.2021.05.005 |
| _version_ | 1784568837185732608 |
|---|---|
| author | Hernández-Coronado, Marcela Gómez-Almaguer, David Jaime-Pérez, José Carlos |
| author_facet | Hernández-Coronado, Marcela Gómez-Almaguer, David Jaime-Pérez, José Carlos |
| author_sort | Hernández-Coronado, Marcela |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8446262 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84462622021-09-24 Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 Hernández-Coronado, Marcela Gómez-Almaguer, David Jaime-Pérez, José Carlos Hematol Transfus Cell Ther Case Report Sociedade Brasileira de Hematologia e Hemoterapia 2021 2021-06-21 /pmc/articles/PMC8446262/ /pubmed/34253503 http://dx.doi.org/10.1016/j.htct.2021.05.005 Text en © 2021 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Hernández-Coronado, Marcela Gómez-Almaguer, David Jaime-Pérez, José Carlos Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 |
| title | Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 |
| title_full | Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 |
| title_fullStr | Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 |
| title_full_unstemmed | Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 |
| title_short | Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19 |
| title_sort | haploidentical hematopoietic cell transplantation for mycosis fungoides/ sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of covid-19 |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446262/ https://www.ncbi.nlm.nih.gov/pubmed/34253503 http://dx.doi.org/10.1016/j.htct.2021.05.005 |
| work_keys_str_mv | AT hernandezcoronadomarcela haploidenticalhematopoieticcelltransplantationformycosisfungoidessezarysyndromeusingreducedintensityconditioningafterbrentuximabtherapydiscontinuationadvantagesofanoutpatientprograminthetimesofcovid19 AT gomezalmaguerdavid haploidenticalhematopoieticcelltransplantationformycosisfungoidessezarysyndromeusingreducedintensityconditioningafterbrentuximabtherapydiscontinuationadvantagesofanoutpatientprograminthetimesofcovid19 AT jaimeperezjosecarlos haploidenticalhematopoieticcelltransplantationformycosisfungoidessezarysyndromeusingreducedintensityconditioningafterbrentuximabtherapydiscontinuationadvantagesofanoutpatientprograminthetimesofcovid19 |